How can the industry empower MSLs as they do sales reps?

Doctors have always liked to believe that what they do benefits their patients. It is, after all, intrinsic to our mission to “first, do no harm.” Over the centuries, however, doctors have not always achieved this goal.

With the incidence of diabetes rising annually across the globe to an estimated 537 million adults, healthcare expenditure is also rising.

For many patients diagnosed with acute myeloid leukaemia (AML), long-term survival remains elusive….

AFTER a 3-year wait to meet in-person since the 2019 congress in Vienna, Austria, the European Association for the Study of Liver (EASL) International Liver Congress (ILC) took place in London, UK, from 22nd–26th June 2022. This year marked the 57th anniversary of the annual ILC event, and welcomed over 5,300 delegates on site, and over 1,300 virtually from 112 countries.

PBC is an immune-mediated, chronic, progressive liver disease characterised by gradual destruction of intrahepatic bile ducts.

The definition and severity of checkpoint inhibitor-induced liver injury (ChILI) have been reported using the Common Terminology Criteria for Adverse Events (CTCAE) used in cancer therapy.

There is growing recognition of acute-on-chronic liver failure (ACLF) as a distinct clinical syndrome that portends excessively high…